Search Results

There are 111332 results for: content related to: A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value

  1. You have free access to this content
    Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer

    International Journal of Cancer

    Volume 136, Issue 8, 15 April 2015, Pages: 1985–1990, Aya Sasaki, Kaoru Akita, Fumitake Ito, Taisuke Mori, Jo Kitawaki and Hiroshi Nakada

    Version of Record online : 17 SEP 2014, DOI: 10.1002/ijc.29185

  2. New tumor markers: CA125 and beyond

    International Journal of Gynecological Cancer

    Volume 15, Issue s3, November 2005, Pages: 274–281, R.C. BAST JR, D. BADGWELL, Z. LU, R. MARQUEZ, D. ROSEN, J. LIU, K.A. BAGGERLY, E.N. ATKINSON, S. SKATES, Z. ZHANG, A. LOKSHIN, U. MENON, I. JACOBS and K. LU

    Version of Record online : 18 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00441.x

  3. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

    International Journal of Gynecological Cancer

    Volume 15, Issue 5, September 2005, Pages: 679–691, M.J. DUFFY, J.M. BONFRER, J. KULPA, G.J.S. RUSTIN, G. SOLETORMOS, G.C. TORRE, M.K. TUXEN and M. ZWIRNER

    Version of Record online : 12 SEP 2005, DOI: 10.1111/j.1525-1438.2005.00130.x

  4. You have free access to this content
    Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy

    Cancer

    Volume 112, Issue 8, 15 April 2008, Pages: 1726–1732, Nilofer S. Azad, Christina M. Annunziata, Seth M. Steinberg, Lori Minasian, Ahalya Premkumar, Catherine Chow, Herbert L. Kotz and Elise C. Kohn

    Version of Record online : 25 FEB 2008, DOI: 10.1002/cncr.23374

  5. You have free access to this content
    A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

    International Journal of Cancer

    Volume 136, Issue 9, 1 May 2015, Pages: 2216–2227, Liang Liu, Huaxiang Xu, Wenquan Wang, Chuntao Wu, Yong Chen, Jingxuan Yang, Putao Cen, Jin Xu, Chen Liu, Jiang Long, Sushovan Guha, Deliang Fu, Quanxing Ni, Aminah Jatoi, Suresh Chari, Angela L. McCleary-Wheeler, Martin E. Fernandez-Zapico, Min Li and Xianjun Yu

    Version of Record online : 18 OCT 2014, DOI: 10.1002/ijc.29242

  6. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

    APMIS

    Volume 121, Issue 1, January 2013, Pages: 38–44, Morten H. Sparholt, Claus K. Høgdall, Lotte Nedergaard, Mel C. J. Heeran, Ib J. Christensen and Estrid V. S. Høgdall

    Version of Record online : 21 JUL 2012, DOI: 10.1111/j.1600-0463.2012.02943.x

  7. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma

    Journal of Obstetrics and Gynaecology Research

    Volume 42, Issue 10, October 2016, Pages: 1326–1335, Dong Mi, Yue-Xiang Zhang, Cheng-Jin Wang, Qiang Feng, Pei Qi and Shu-Qin Chen

    Version of Record online : 16 JUN 2016, DOI: 10.1111/jog.13053

  8. You have free access to this content
    Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure

    European Journal of Heart Failure

    Volume 14, Issue 9, September 2012, Pages: 974–984, Julio Núñez, Eduardo Núñez, Gema Miñana, Vicent Bodí, Gregg C. Fonarow, Vicente Bertomeu-González, Patricia Palau, Pilar Merlos, Silvia Ventura, Francisco J. Chorro, Pau Llàcer and Juan Sanchis

    Version of Record online : 27 FEB 2014, DOI: 10.1093/eurjhf/hfs090

  9. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer

    Australian and New Zealand Journal of Obstetrics and Gynaecology

    Volume 51, Issue 5, October 2011, Pages: 397–402, Yu-Li CHEN, Chia-Yen HUANG, Tsai-Yen CHIEN, Shih-Hung HUANG, Ching-Jung WU and Chih-Ming HO

    Version of Record online : 9 JUN 2011, DOI: 10.1111/j.1479-828X.2011.01325.x

  10. You have free access to this content
    Carbohydrate Antigen 125 Predicts Long-Term Mortality in African American Patients With Acute Decompensated Heart Failure

    Congestive Heart Failure

    Volume 16, Issue 1, January/February 2010, Pages: 15–20, Ibrahim N. Mansour, Sirikarn Napan, M. Tarek Alahdab and Thomas D. Stamos

    Version of Record online : 10 AUG 2009, DOI: 10.1111/j.1751-7133.2009.00110.x

  11. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma

    International Journal of Gynecological Cancer

    Volume 12, Issue 5, September 2002, Pages: 438–442, U. Saygili, S. Guclu, T. Uslu, O. Erten and E. Dogan

    Version of Record online : 15 OCT 2002, DOI: 10.1046/j.1525-1438.2002.01171.x

  12. You have free access to this content
    Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment

    Intervention Review

    The Cochrane Library

    Tilean Clarke, Khadra Galaal, Andrew Bryant and Raj Naik

    Published Online : 8 SEP 2014, DOI: 10.1002/14651858.CD006119.pub3

  13. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue S1, February 2006, Pages: 99–107, M. MURAKAMI, T. MIYAMOTO, T. IIDA, H. TSUKADA, M. WATANABE, M. SHIDA, H. MAEDA, S. NASU, S. YASUDA, M. YASUDA and M. IDE

    Version of Record online : 24 FEB 2006, DOI: 10.1111/j.1525-1438.2006.00471.x

  14. You have free access to this content
    Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer

    International Journal of Cancer

    Volume 130, Issue 5, 1 March 2012, Pages: 1136–1144, Yongjung Park, Yoonjung Kim, Eun Young Lee, Jong-Han Lee and Hyon-Suk Kim

    Version of Record online : 14 JUN 2011, DOI: 10.1002/ijc.26129

  15. You have free access to this content
    The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters

    European Journal of Heart Failure

    Volume 7, Issue 2, March 2005, Pages: 199–203, Nikos T. Kouris, Ioannis D. Zacharos, Dimitra D. Kontogianni, Georgia S. Goranitou, Maria D. Sifaki, Haris E. Grassos, Eleni M. Kalkandi and Dimitris K. Babalis

    Version of Record online : 8 FEB 2005, DOI: 10.1016/j.ejheart.2004.07.015

  16. You have free access to this content
    Serum Carbohydrate Antigen 125 Levels in Nonischemic Dilated Cardiomyopathy: A Useful Biomarker for Prognosis and Functional Mitral Regurgitation

    Congestive Heart Failure

    Volume 18, Issue 3, May/June 2012, Pages: 144–150, Oguz Karaca, Gamze B. Guler, Ekrem Guler, H. Murat Gunes, Elnur Alizade, Hicaz Z. Agus, Gokhan Gol, Gokhan Kahveci, Ozlem Esen, A. Metin Esen and Muhsin Turkmen

    Version of Record online : 12 NOV 2011, DOI: 10.1111/j.1751-7133.2011.00260.x

  17. Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer

    APMIS

    Volume 114, Issue 5, May 2006, Pages: 359–363, ANETTE LYKKE PETRI, ESTRID HØGDALL, IB JARLE CHRISTENSEN, SUSANNE KRÜGER KJAER, JAN BLAAKÆR and CLAUS KIM HØGDALL

    Version of Record online : 24 MAY 2006, DOI: 10.1111/j.1600-0463.2006.apm_397.x

  18. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma

    European Journal of Haematology

    Volume 78, Issue 5, May 2007, Pages: 399–404, Christophe Bonnet, Yves Beguin, Marie-France Fassotte, Laurence Seidel, Françoise Luyckx and Georges Fillet

    Version of Record online : 28 FEB 2007, DOI: 10.1111/j.1600-0609.2007.00843.x

  19. Clinical evaluation of salivary carbohydrate antigen 125 and leptin in controls and parotid tumours

    Oral Diseases

    Volume 22, Issue 7, October 2016, Pages: 630–638, K-Y Zhang, C-Y Liu, L Hua, S-L Wang and J Li

    Version of Record online : 4 JUL 2016, DOI: 10.1111/odi.12505

  20. A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue 6, November 2005, Pages: 1023–1034, T.G. EHLEN, P.J. HOSKINS, D. MILLER, T.L. WHITESIDE, C.F. NICODEMUS, B.C. SCHULTES and K.D. SWENERTON

    Version of Record online : 17 NOV 2005, DOI: 10.1111/j.1525-1438.2005.00483.x